PW MEDTECH (01358) · Company profile · Eqvero

PW MEDTECH

01358HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	823.51 m CNY	768.9 m CNY	675.08 m CNY	536.83 m CNY	271.4 m CNY
Cost of revenue	276.19 m CNY	231.71 m CNY	195.93 m CNY	159.42 m CNY	73.93 m CNY
Research and development expense	48.41 m CNY	44.12 m CNY	41.13 m CNY	40.98 m CNY	22.68 m CNY
Selling, general and administrative expense	268.86 m CNY	240.88 m CNY	195.11 m CNY	189.57 m CNY	122.62 m CNY
Operating profit after depreciation	125.71 m CNY	174.01 m CNY	191.84 m CNY	98.17 m CNY	49.95 m CNY
Operating profit before depreciation	265.57 m CNY	291.75 m CNY	290.1 m CNY	176.75 m CNY	81.36 m CNY
EBIT	125.71 m CNY	174.01 m CNY	191.84 m CNY	98.17 m CNY	49.95 m CNY
EBITDA	265.57 m CNY	291.75 m CNY	290.1 m CNY	176.75 m CNY	81.36 m CNY
Interest expense	720 k CNY	374 k CNY	154 k CNY	464 k CNY	605 k CNY
Profit before tax	164.99 m CNY	229.75 m CNY	231.07 m CNY	157.75 m CNY	737.46 m CNY
Income tax expense	29.74 m CNY	37.23 m CNY	26.04 m CNY	28.88 m CNY	-1.65 m CNY
Income before extraordinary items	94.37 m CNY	150.78 m CNY	153.18 m CNY	106.04 m CNY	739.12 m CNY
Common dividends	84.65 m CNY	137.68 m CNY	139.98 m CNY	—	—
Total dividends	84.65 m CNY	137.68 m CNY	139.98 m CNY	—	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.